<SEC-DOCUMENT>0000849146-20-000027.txt : 20200114
<SEC-HEADER>0000849146-20-000027.hdr.sgml : 20200114
<ACCEPTANCE-DATETIME>20200114104405
ACCESSION NUMBER:		0000849146-20-000027
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200114
DATE AS OF CHANGE:		20200114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		20525258

	BUSINESS ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kpreliminaryfinanci.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_21"></div><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;-sec-extract:summary;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">UNITED STATES</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;">Washington, D.C. 20549</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%;">&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">______________________________</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:103%;">FORM 8-K</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%;">&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">______________________________</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%;">CURRENT REPORT</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%;">Date of Report (Date of earliest event reported)&#58; January 9, 2020</font></div><div style="text-align:center;margin-bottom:7pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">______________________________</font></div><div style="text-align:center;margin-bottom:7pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:center;margin-bottom:7pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Exact name of registrant as specified in its charter)</font></div><div style="text-align:center;margin-bottom:2pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">______________________________</font></div><div style="text-align:center;margin-bottom:2pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:27.487%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.051%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:24.923%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.051%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:27.488%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="15" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">001-35647</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90-0224471</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other Jurisdiction of Incorporation)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Commission File Number)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(IRS Employer Identification No.)</font></td></tr></table></div><div style="text-align:center;margin-bottom:2pt;"><font><br></font></div><div style="text-align:center;margin-bottom:2pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">9785 S. Monroe Street, Suite 400</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Sandy, Utah 84070</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Address of principal executive offices, including zip code)</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(801) 432-9000</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Registrant's telephone number</font></div><div style="text-align:center;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">_____________________________</font></div><div style="margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions</font></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:7.809%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:88.191%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">o</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">o</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">o</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">o</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td></tr></table></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:30.905%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.442%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:30.905%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.442%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:30.906%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock, par value $0.0001</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">LFVN</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The Nasdaq Stock Market LLC</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading symbol(s)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</font></td></tr></table></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o</font></div><div><font><br></font></div><div style="margin-top:8pt;margin-bottom:8pt;"></div><div style="position:relative;width:100%;height:72pt;width:100%;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o</font></div><div style="margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 2.02.&#160;Results of Operations and Financial Condition.</font></div><div style="text-indent:36pt;margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 9, 2020, the Company issued a press release announcing its preliminary financial results for the three months ended December 31, 2019. A copy of the Company&#8217;s press release is attached as Exhibit 99.1 to this report and incorporated by reference.</font></div><div style="text-indent:36pt;margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.</font></div><div style="margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 9.01.&#160;Financial Statements and Exhibits.</font></div><div style="margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(d)&#160;Exhibits</font></div><div style="margin-top:8pt;margin-bottom:8pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:10.199%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.528%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:82.271%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit No.</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2.25pt;padding-right:2.25pt;margin-top:2pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Description</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;margin-bottom:2pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.1</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2.25pt;padding-right:2.25pt;margin-top:2pt;margin-bottom:2pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">Press Release issued by the Company on </a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">January 9, 2020</a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">, announcing its </a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">preliminary </a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">financial results for the three months ended </a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">December 31</a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;">, 2019</a><a href="a1-9x20pressreleasepre.htm" style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;"> </a></font></div></td></tr></table></div><div style="text-align:center;margin-top:8pt;margin-bottom:8pt;"><font><br></font></div><div style="text-align:center;margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SIGNATURE</font></div><div style="text-indent:36pt;margin-top:8pt;margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="padding-left:2.25pt;margin-top:8pt;margin-bottom:8pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.198%;"><tr><td style="width:1.0%;"></td><td style="width:24.332%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.269%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.932%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.239%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:38.228%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:2.25pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date&#58;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 14, 2020</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By&#58;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">LIFEVANTAGE CORPORATION<br><br>&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name&#58;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Steven R. Fife</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title&#58;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:2.25pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:9pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;width:100%;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a1-9x20pressreleasepre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_21"></div><div style="height:72pt;width:100%;"><div style="text-align:center;"><font><br></font></div></div><div style="text-align:center;"><img alt="image1.jpg" src="image1.jpg" style="height:63px;width:306px;"></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:115%;">LifeVantage Posts Record Second Quarter Preliminary Revenue, Introduces Free Shipping in 2020</font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%;">Preliminary revenue of approximately $61 million represents the highest quarterly revenue in company history</font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%;">LifeVantage to ring the Nasdaq closing bell today in celebration of &#8220;Wellness Week&#8221; </font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%;">LifeVantage to present at the 22</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:115%;vertical-align:top;">nd</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%;"> ICR Conference Jan. 13</font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;">Salt Lake City, UT, January 9, 2020, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">(GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq&#58;LFVN) today announced preliminary revenue for the fiscal 2020 second quarter and six-month period ended Dec. 31, 2019. </font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">Preliminary revenue for the second quarter of fiscal 2020 was approximately $61 million, or a 5% increase compared to $58.2 million in the prior year period. Preliminary revenue for the first six months of fiscal 2020 was approximately $117 million, or a 3% increase compared to $113.8 million in the prior year period.</font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">LifeVantage President and Chief Executive Officer Darren Jensen &#8211; who will ring the Nasdaq closing bell today in conjunction with Nasdaq &#8220;Wellness Week&#8221;  &#8211; commented on preliminary revenue second quarter revenue figures. </font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">&#8220;This is a significant watermark for us as a company, particularly on the heels of achieving our highest annual revenue in company history during fiscal 2019,&#8221; Jensen said. &#8220;Our continued sales growth reflects, in part, the positive reception to the launch of our Protandim&#174; NAD Synergizer&#8482; and Protandim&#174; Tri-Synergizer&#8482;. We are excited about how we&#8217;re positioned as a leader in delivering innovative and effective nutrigenomics products as we enter the new decade.&#8221;*</font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">LifeVantage&#8217;s introduction of free shipping, which goes into effect in select markets beginning Jan. 13, 2020, will provide incremental value to customers and further improve the consumer experience heading into the new year. All subscription orders and any spot order totaling $100 or more in the U.S. will receive free shipping. Orders in Canada, Mexico, and European markets over a certain amount will also receive free shipping, with purchase thresholds varying by market. Free shipping in other markets will be rolled out over the coming quarters. </font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">The Company released preliminary second quarter fiscal 2020 revenue in advance of its participation and presentation at the ICR Conference on January 13-14, 2020, in Orlando, Fla. The Company does not intend to release preliminary quarterly revenue on a regular basis.</font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;"># # #</font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;width:100%;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div style="text-align:center;"><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;">About LifeVantage </font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">LifeVantage Corporation (Nasdaq&#58; LFVN) is a pioneer in Nutrigenomics &#8211; a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development, and distribution of advanced nutrigenomic dietary supplements and skin and hair care products, including its scientifically-validated Protandim&#174; product line, Omega+ and ProBio dietary supplements, its TrueScience&#174; line of Nrf2-infused skin and hair care products, Petandim&#8482; for Dogs, Axio&#174; Smart Energy Drink mixes, and the PhysIQ&#8482; Smart Weight Management System. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">www.lifevantage.com</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;">Forward Looking Statements</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as &#34;believe&#34;, &#34;hopes&#34;, &#34;intends&#34;, &#34;estimates&#34;, &#34;expects&#34;, &#34;projects&#34;, &#34;plans&#34;, &#34;anticipates&#34;, &#34;look forward to&#34;, &#34;goal&#34;, &#8220;may be&#8221;, and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding the benefits of our key initiatives, future growth and expected financial performance. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption &#34;Risk Factors,&#34; and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;">Investor Relations Contact&#58;</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">Scott Van Winkle </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">Managing Director, ICR </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">(617) 956-6736</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">scott.vanwinkle&#64;icrinc.com</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;">Media Relations Contact&#58; </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">Chris Taylor</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">Communications Director, LifeVantage</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">(801) 432-9170</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">chtaylor&#64;lifevantage.com</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;"> </font></div><div style="position:relative;width:100%;height:72pt;width:100%;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
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M>+"'$1/F1>/ZC7*ELD7W8@]=@&[X0C;4I+1/ONZ/Z>OVHK*Z5O2<>J%*0)6
M*@&I!%H$R++S2S%F1CCNT9OM8#HO?.2Y$1>NY4O+LWE=W]" 18$'\=2@  :$
M6N>)>.F3N0C9<\9F.O5'50*J!.YL"=P6D%55UV+AMH/XW4 >>'SA].\%(.WJ
M=C8:5OXP.Q(/=#=R@*8W8N"8E4A*S;R=;-6TJ@14"?Q")=!L( O=>PXO_FNV
M>2CHA]\/FH3Y6Q-16U??8J(Z=R47'[BM8U0-FA"XU]D+W\\,!VF =_)6UW +
MA;5 84T#"FMNH:Q6;GN\D^6CMOW.DT"3@>QX:B;>&;_&#"[^N%OO@3$SPY%3
MT'K@$I60RMG/##Y,0R/07!IR&'4M")J=X=7ONUZ-[TX6XY\[<M$E+!M=@M/1
M)30+?XC(PHB395B;7H6":A74.L.[5.O8LA)P&,@*BBO@NF [[G6FV<4 1FK]
MP'4]DE+:9KA75]^ F>OWX;<#_,W\,Q_\<]@\A.T]:Y%(PLFKB#IP'E&)%Y!Z
M-<]ROZ.='+U1@\2":H>K551=C\$'BZ )N0[-]G)HP@J@"<J&)BB'.X;D01-=
M!LWN!DQ)*7$X7_5!50*_% DX!&1D@'_FS4D6 NO+G\Q#J ! VE(8V06E^'YF
M!+3=7,V :L2_?;?@,Y\MG-< S9@:O/'K5[TQ?6U\6U;-;EF)^95PWE\,;6 F
M-,$YZ+&_" G7;;MI%537H]NN/&AB*Z'9E@G-EFO6]Y@*3#I7;+<>Z@.J!'YI
M$K )9+&'SN/5D<N@=>:&=(_U]<7L30FHJ:UK=SDD)J?AK1_60*OS8L!%+D\,
MW+I-@)9VY@IE1&1"2KO7E2IPJ:P.#X7G<IH3 =*V#';^8$@6SA9;=]%Z-^$Z
M-'&5T&Q)DP/8U@P.W"@O KCMY:I&UB'>MEJ)MI: 52!SFQ\%K<'(M)[_,GAB
MU)10I&7?:.OZV2TO:,\9/-#="UHG-P[ >""CH\&$ =\MMYN'](&<JGI<*:]#
M6D7C3M>W8W_ZX601-#$5T&P6 E(: ZGO3RC+=?_U*FXXR0.54!N+N $-#2FW
MID,3F 5-="DT\<#D%AA:%I=5XE)Z 7O?],[Y_7)F(<HJJJ3B:M9U=4T=*#\^
M;_[X<T8!"DMN-BO/]DA$E"'R4KF:U2BGM.PB=DVS^NK6-A)0!+*-,2<X+4QO
M0J__+,'A,]?:IC;-**6FK@Y=7C,R'TZFB0F!3&]$[U%+FYQKW_@\=(TNQ",A
M&9:]:UPI1B4I XXC!3CORH4FHDBN56TOQ\ACA8I93#A5Q-G$A !&Y^&%Z+>_
M$*&9-Y%24HN#^55P/56$?R24(^#<[=O("$R>'."'1_OXXM'>WI:]:Q\_#!S=
M] ^#4N.^F1J"KGW]+7FS<OKXX.%>)A"QNK-L9#M^_L,9>+3OQ,:V]/%ALDM,
MOMI9FM'IZZD(9(;/%S![V. ?U^#6K5L=NI'DM_DT$6C)Q4D(8DPC\\9'[NN;
M7/^7XW*@V5YF-J:303T'FAU5^/A009/SXA-,2REA><AL7+&5\#VK;-=Z(28;
MFK!\,?B%W\" _050>BU5=?7(JVH9^LN@[U> ",GDY&_92<8ZC]L&FORB"CS2
MVX>;^1;F;Z )G+FH[@"F"_Z]V3OF%9;A-WTE;2&SALX3\4D_VTNN_MY"$I !
M&:G)%)V"HE)$'^@8]B5[;5T<>)#CLU%X()H$Z/8CZR3W.7OB[.5<>\EEOSOM
MR&%:CPATHDOQV>'F UE133V<=E^'9F<M-*'7N7U'%?X4F87K5L#G>2F0D4TL
M) \)UUMF>"=KN.!&:/Q9#FB8/,UV1_9Q\,&/\R(%3S;]=&784<Z-3>'#LVC;
MP:9GV(XIR/WN]P/].)LLWQXG5V;JV'?B<CO6[,XJ6@9D%#>,V9L,W@C?=Z[3
M2&-YR&$\-V06[B=[F<X3+WT\K]E?Q-8 ,A+DC>IZN)XMQW.Q>?AK3!Z,Y\J1
M4VE]XD2FD9&M+# 3*:76)P=:ZH61C^M?!D^5:[HZ3_QI\!14U5BOMZTZD(;?
M_]N?H-6;Q!HTA7?JZ^N07ZZM_-OZ-Q7(VEKBRN7)@.S(V71.JS%XBSA:RLD[
MUMVJFEJ,FA(";8^I<)T7U>S*M1:0\16JJK^%RGK[0W9E(,M"LHU93KZ,ECAZ
M+HKA9H1Y38,_ZKVP/3&U6460_>U> PU7)9,S!F]\:MK4K#S;,Y$*9.TI_<:R
MVQS(5E\I0X_$<KQ_N!A9-YOW56^LOOSLQSE1#,A&3P^5_^C@G=8&,@>K@?8&
MLO-IUW&_B\*,L,&$8:;-CC9#]-S,=7OEX.CDBGN<3=A[O/,-Q50@$[W>=KMH
M4R"+SZOB;$-$%=A5A][Q+<^^'S<KXA<#9/\7FPU->$&CL9\-+;.0WLP/ +ED
M%M7>0E%- SO6--C7"ON.6F:VE0GL9$X>Z-K+V*QAX"N?SN%"G?/:'1UU7OC?
MCV:TR\02#76);D+K1Q25<L>2<L=MD+: +/E2=KMU[*843.T5MI_DT9(;3<BQ
M_,TR;LF\^;S:%,AT9$2/*N'(G<1_"B]$5%;+"JVC AE!QJ24$HP]4XZQ)XL<
MVA\+S>0X8CS]@F2V-0.?'"H0IT\NA6MR,0H5_"SSJ^NQ^EHEQIPNQ__%YN#1
M\!P\&I+)CB_&Y+#[*],JD6]EPF%3[$EEP[S>A+61Q_C_D4-'BOY+OKDBXC(!
MF=Z$.1OW6_(H*KV)<;/",6YV).A]*NZS(^&U.*9)$5&(GY9R-1\_A1[&N#E1
M^&Y:*+I_N1"/]_-A]CF:Y"([W1/])^+=']>P9Z(3+Z#\IG5W,D4@8R#MBB%N
MZY3KSK=I=B1^F!.%K.N-E!DJR[@X%N-F1UE/.SL2;O.C<?1<\]P#B;.W(NPH
MQLV)QIO?K\1O^_D*VN_#9F%[CEB,,3/"V#N(/701E]*;%I(KY6H>?);MP*>F
M+?C]0'\N_[X^;")QT)B5K&W[3EQ1#+9J^2,TX:3-@.Q ?A7N(A]!(;DSNA0?
M'FR:@.RUK2,#V6.A&=#LKN>H'43OL+>3!X"(0&MV3XHL;DQ+/I;[ -W.7%!4
M#'XKKFF ;VHYGHHM@(8]7PY-:+[81Y.NR7<SJ@1/Q19B>JK<\9^^ID\.F"B>
ME:..:C"AS]=-X^B-GQ,!+3G^LXYNUO"<W/%@#T]19UZX-1':[I,Y+J/!FQN*
MRHX^W'V=.P:,7F4U: '-6J^,2,+;XU;AO]^:PE%):':;ZD%YTKF0 D+GM+X$
M>8K0,WHO/#=D)C;'G>1%*SI:!S(":,K#6OV]H>T^"<^^/5FT^,Z6'2<YUSOR
MIK&:EF^[!WI\M10G+S@&:,=3L_!OWVUXN!>UVVCFBAJY]DIEP&1$=?=A[_X^
M@SOZCUZ)^5L/@,C,UK93%[/P+Z_-^"^#A[G^)NZ_(\R?EZW.$RY?+L'^%IC=
M;3,@FWF^U$SN%##;@TD[2$=A=<MPGTBX'1G(_AJ=Q0VM>0VK18[IT$84(2BC
MD0V?45&+EW<70!-[DV/_.U(.44*B2S'T8(%L(H)")\D!R(W-$),=S9&-9D'_
M0/ZZQ+$2 IG!A$^-8B._TV?SY,-981KA.5$=G'WQTL=SD5,@#X_^+\\-##!8
MU&)6-M%S:!<,E6V>NW)@IS=AWN8$65-M IG-?.ECX(TE08=$>0[X5F$H;S4?
M5_9>GG@] !>O67\/#0VW,'YN%.[KSODA,^"VFJ>27#@Z"0-6)S=%.5,CUF\_
MC@=ZF %2.IFC6![5WX3[NAL1<9L,B38!LKI;0+>=>5S4!F&G(NUL6Q;VYUM7
MW45OV8&+3@EDQ ]3VH6R$IZ;AY@L35@!_A2=C3HS0S:KLA[/Q5&4C+)&VQJ?
M-C ;FL@B;B?MF,KD?Z,CO8^X2HPY+N;+'3N7@;M(2Y$"@,$' 2MW.?!6P*@\
M3/L1_:%=&;UCU]%+ECP.G4[#W09>2Z(.)-E%Z06=SF4B/O;:".JTPFVX[Q9.
M,["6CMT7E"%M(Y^.- J]"4&[3PNS9W9"&8^,3\/RXH%3<M1YX*%7C:*U*<[\
MG,O)F6DO@CJ1#*S5BSB3SK[XP'6MJ%[\1=G-*KS] X6?]Y'/%//UE,G8"M [
MN>'7/;U$=>;+F;\E@?OX2#]45 81J4D+H]W*[P_T],%NP?^ S]?18ZL!65EM
M/8(R*_'AP0*\0B!&_H!;TL4=ASI/8!:ZAF3@C8/%<#]3AI/%M^>?UBF!C _)
M$YS#HF)PX7ER.#]*(=#PY\+GXZHPX13G.E51UX 7B41+PTW+D#2-<RR/*L&O
M M/1?V\>7M]W'?\@[P7RU0PO%#S+O0^ZMU= NB6,[#EBD5Q+TGOAA0]G@$(L
MV=O(PX)I17SG87]P,O+/1%5UXU!E^,2M'+F9ONA*.]\AA/G0N9,[[M&YXJK$
M'_ASRH^&:*+G?^2&DVSH9C(/+<WE4:>C""I*P*$WXN_O3Q,-K6QJ9*S^ L\(
MX?#*V1<C @)%8B.[((&28KLI+ZMM=\5=>@^<OI0CRH\F,K[T(WE.M-(>6E^6
MVJ\@:RI+*@,K0$8>#$S;DX(47>N\\+?WIF'@F!5L)WL9DR_)0OA.]";\_?T9
M-NV1HL9)+EH%R#:GE>//L?F<;8:,^_3UYSNA[)C&V6W(CA-=BGM"<O'Y\5)D
M5S9ON-FI@,QL+UQ[M1SD(![/[WF5B,^KQ+.16="$Y#;*CC2H;9E8<:4<"?G5
MV)-7A?@"<F;G9&4Z;79,M\B89$O@F N/,R6X7-X(&&1/B\NM@H%"!(7?$(-9
M9#'ZQ8L](E:$'9$#43=7ICW9HTV0M\B#/91H'-XRC>[@Z32<O)"-Y$M*>PZF
MK8W'@-$KY3.?U"D,WIB]89_H+ZX(9$[NS*WMVVEA,"V)!9' ^?+61B5A\(_K
MS'8=J69"&J0'=AV]:"E#$<C,&M3<S0DX<"H-\4F79?ON8Y=EF@W5X=3%7$M=
M^#K1\>2%+,Q8MQ=OC5O# :\49 PF3%HEUH[71!XSFP0D[3"#XBO#YF/B3W%(
MOI0C*O-82@;C8;)@#,)R%("LLJH6SP^9(?]OZ(UX:M DA,2?8\L_\@++NU&.
M!5L3F6^J;(AK\ ;)OSE;BP/9QK0*SCF:OO26#F4CAI;T&8K5%5>%Y[9G6YU)
ML]70S@5D7'RQS)O*H,VT*^%'@( O, L_E\NU5O*Q[!)"P)?7*/=M&;@K+!\K
M+\MM1[P,28O[6TRNV*<S,!OW!V7BY[+&<FB*GGU-I5]=@S=&3@KBLU,\+@L^
M+/^C.[FA:V]?%CE",9&=F^].6"O7$ V^\%D:)TJI"&0&;[8\H>A!R<6<30E<
MB"AA1R:P=/;!K(V-8&D5R)S<<"PE79)KRUQ^,S54H>TFO#UNM:4 6E?VK^^1
M9P:Y[0F&X 1B.@_XK=AE5Y-^@B9YA)J3 I"MCTZ2:[PZ#SSUYF2<3[-.K]JP
M_;AB&]Z?H#Q$MC3,RDF+ UFWN%S.J&\9VC0!Q'A0(QM09#'.E31V)"OUE]WN
MC$!VOE2YG4TAQ*Z\PLT^-GX\TMALY-!$^[/"1%+64%B@K8)W%5V&-5<J1/+]
M>DJ0XI_VM_U]D5]D?<F_'DK#4H,WWAG?V/%$!3EPL7#K 7E=#-X8/T?L!VH-
MR-9$VO_R]_N&#.\2(#!XP_>G'98:V@*RUO*UC-R?(O\P&$SXP'6=I5ZT$#8;
MB@I!C&FM)AG86Q()3FBV^O%^-,P5# $E0$9#5]F[)6U4YX7H _8]/WI^M5@L
M7YT['N_KBUR%21M!U11/6QS(UO =2JA)\ #ER)$H!W%5^'.4=6=JQ9:8;]ZI
M0$8T%A:3C)?QMDS<'Y&/9 =LCA=+:Z$E&Z9YJ,O ,+H4BR^)-3E:K^%>%[*I
M2(8J>I-5>@+1'RB>G;:;T"6)_NQ&4(=L[L8<SYD=1Z!M&$SXTF^;*$MK0+8R
M_*CH.:4+CBXBL:_IC6Q!'/[Y]@&R5+M -FIJB-R?5>_);'R.V#0= 3):[:Q+
M+[.-D0=,O1<,P^?SXK%Y9%HO34+P:9FMSI7%PK.94.''%@<R*H.^\,]L-W<L
MLGT17XGO8+)C&C<10+&ZB/$?G(.A1TMQK:+1GJ-0;ZNW[D0@(Z8^#<595 U>
MOL%Y>"8\@P6')$^ ])OU5O8Z'"FHQJ/!&9P]C4\?4:08[4,W?+[\2Z^G )8_
M*;X3[V6Q<LU)YXEGWO '#7_L;?0,K8\JW7V6Q8F_YF9MXRN) ?UV@(S<W&03
M!7HO]/UFF:7:K0ED%(E9VFZZGK?Y@/P=2#2RUT8NE3^C-\%K<:RE[K9.' &R
M==''%0'U<]^MR,PK1GJNC3VG"*[SH\7R=7+%74ZN2+EB?4AJK<ZM F14&(6M
M69]>B;<2\O%"+#]K*1BZ\!UF6R8>#$I'GP/%^#ZY#(<*[?^YK36&[M^)0':A
MK([16*1TBKNV7L-#0>EX*)CV#.4]*!T/!V?@;D;I$+R?\$*0SZET6Q9R&%J]
M1$MQ<L.O>AA!#N'"C88>-*LIBQ5G\(;W$NL=BHB;OC_MPGNN&[CT_!?;WM%@
M0EL 67\!:+<TD)'A?<KJ>-;V?WPRIU%;<:#MPJ$E14:6#2WU7MA]S+$8:8X
M&6FU,J#O-@$/N'B@RZLF/-S3:'7O\JH1]SM+O#S,DR1'SS;=MMAJ0";\0U?6
MW<++9#N3#C?-QNM=>8[[M@GS53J_$X&,U@/0TH=!MCA)NIG)3RLNV=D)R/B/
M"QW#"]%- <AHV3_B/XEL)TP;\L&D5;M%KV3_R2NXA\*E"PWF3F[LJTMKEDJW
M:SDW\+[;!HY+Q5,CB Y!?W I14"8)]_).S&0_9R1CZ&>&W$O.>GS;6=>!SR?
M3$B1D SMF?S%-C)K0!9WN''&52I_X;4C0+::S8I*/FI4%_:^K-!.A!04>J?\
MN^/3=7-%AP4R$M"TU!(S25/ [ _*0=?@=-RHL<]#$@K9UKD*9+Q6E<817FG(
MSI-@FW+<58?GHK,41?V%$C=+[X67_C5;-!,V:DJP_(NM-V+0F.6R"+=D?WOF
MK:EFXJ:PHQ*SWDRF%!ZELZ?FSMP9-3*BG#PY<#(G*U'GYKT*).TG<"<BK! $
M)$-+:T 6[V"$D>8#F9FC)WQ7CIX3?T]OPJ'330^MWR8:&?4&XDEI*6RSQ*#\
M_@'KKA6*O<C.S3L1R&C6DSPD1$/+H%P\&9:!\*Q*A&7>;/J>4X-] E*L4.Q[
MCOUL'BZ* ><NO2<.G.+BU%,DB2?Z^\J9W'HCMNU,%F8'BGM/I$G9,(5]O=W0
MXZLE((;^HFV)H/4D G<GLVL92[P3:F0WJVKQXM#95MKN@>XC%N-CSXV@*,A\
MVT?/"%,8KHLULCY*44L,1DQ?MU<D>VL7C@#9J@CBJ4DT,ITGAGEO9IX<M.9L
MD_9]YQ"V]QR+0F*M7M;NMQF0405>H; T9/RGI<UH*!-Q@W4P:Y5KSOT[$<@H
MPL4SX9EB#EE('IZ)5-:HFB-789K:NGJF?2E1$T9-X3AE@;N2Y38:G0=SDB:_
M2^'&;"W$:!=J&$[N>*2/K]7@GJLCCLKS[V! 1D-K>QM;Z$<*!D[NZ/*:CU7_
MP^V)Y^4 (M'(/O)8+Y>/W@LO?C33H7!)C@"9XM#2X(VO)]OF%=J327-^;U,@
MVY%3R=G)",QVUJ+'+KF=I#F-$*:Y$X&,VO_> <[I6VCGTD858]X%>40+H;R:
M>SYE]1YY9])YX)DW E@TAP_<B+ J"6=M\,8$A<B] \=(#=/<<'*6A*4OK"MI
M9S)C=CL &2T^\KO7I=%!.!]2TESM;4,)<)A+E)A&0B&*K&V!NTXKIA$:^Q4!
MDCX4>B.6!-I?%\$1($O/+<*O>TKLI0R$O5MTZ4BRRY)G@ZVM38&,*K+D4BFZ
M[2_#H,0BI"DPU&U5UI'?6@W(MI=AQ%'E9=L<J1>Y,O]5&OW";)QO"4+LBLME
MYEAOO(WL&J-3=(G,MSI$=*3>UIZA/U=76@E)2)BDCN+DQMR.?O>Z'V>@Y[4L
M)S?<Y^*%U*MR4\(+'\Z44"G(P.UN\\_;48",AL5/#9(L/L( PX2EP>+(%DJR
M'.JQ01&4HFPL_.,(D-'[^4T_8N9+HHTXN>->%R.(.F%O^VU_^\Q^XHS)/BAZ
M+^@_7X3"$C&AVEYYTM\;;MW"3R&',6?3?N:)02Y82O\?2M?F0":M;$M?MQJ0
MA1>RB+;1V96(S+II9Z]$6%8E*!(%O[4VD%$HI"?")5PR\JX(R\>O0G,P+;44
MI10BUL96?^L6+I35P_U<!?K$YX'6%K"U#7%?)]?*:#:1\8$$&H99$WAMY!+%
M[%[Z>+8$R+A@BR8;6DE' ;*Z^GJPY1.E'@!L&#V5^3$*&UU160VRB_$;N>3(
M-3(CW!=$\X_(CHX &27R6+B=<T+G/R;\D2*9.'G@"_\@[#A\D3EJ4T!'?B=-
M<LK:O1P]0DA^EC#[J0SF:B0DM?)E&+SQRK %V'GDDMVA+,DC*B$5[[EMPDR!
M%D[UF+IF#[/KK8\YB0TQQ^&W?">4%CZ6 5EB<AKW)>UDJRCQ;]MU7C0+=?W=
MM!#^5I./BC'[-YOI#2Q"12YSQ"9G;,6=_!UC*K ^K=%MI[6!C!I)PT@6*%%(
MI2 P(\?QB"(\%9Z);T^6L!GDPP75;!$3 F;3&8H\4H)7XG(8Z&EV5./AX'3<
MK+,-?!1VA>.("8W^!&#2:W+H-F)3[ G%=S%N=H0<$!DWS80-,<H!#5>3H9EF
MP_B.0\=V&%I2@RCBJ0R,J#XZ#]"2A(/'KV:@0HL2/_7&9 P>O\8BAQ_G1BJV
MG;PAE@0?%D7:X!,Y8B.C9VEX^)=WIRO7C0"*;'-.;FPQ9EJ0F=\9?8+9[23O
M40'("%2<ALU5+H/ 7>?)@-YC42S3 D]=S&;KHI)=U&-A++Z>'-RX+FWW21@U
M-9AO)I:''F;DV/&S(YAF1M&*R?:J1,^0 =FUG"(\:E[7LKDKY5AJT@XG'] 7
MKL=DT-1_<S=%("-N%0$$S;HJQ0X3WJ,A8V01-EYK5*W; LBHO>\?R(<FME(Y
M!! !+X7X(1LE'XN,0(X\*BA2+,TJDZM2<"Y^'YYI%\AJ:NOQW ?3Y([)0G Q
M=VCRQ[06"YY]/!E?3,HKHFBMGG#Y8@$^=%_/%CRA&3PZ9V11$56A_8",1;25
M&NQY&5 ="7!):Z%GG'V9?R+_WZ20T/>Y2.Q,E-:<[N6/YUC:3D$BJ>W.7RR4
M#^DEQGX^_X235_!0+RI;8J^TU(^+Z,%F@%G8'0^Y"YKE6>5X9"?.9S*S@5:O
ML$@V?=0(T*C]C#9B_M"1,SLO$T:EH>=,&#LKG*\Z-L:>P)%SZ?!:% .B_!#C
MGX;$5[.XL%66!Y6&EO2C[M_SV$KC0YJQ2K<P\[8^IZ7L[C='P0S9<Z;9Q5L%
M,B%AU-8Y 5YX(3:U Y 1)^^-A$(.G BD:(985E<"Y$QNYP%-^$Q('AX)24=%
M;>/0V)HP9ZY76!6)_^/S1X,WB_]N+0^Z/WI:*/O/L0[,IV-'OB-0=%/!;ND4
M@B%L.VED93>K\?0;DYC6*=(01>TPUU-O1&])B' 6A\Q%8E/DTU([A>VF<]9V
MVSPRH:PI6*5N^$)NF*DD-[XLX9$-*>UK9'PYD?O/H4L?/S-@2M)9\N7)O?2[
MPC,&'Y%&EIU?RD(7T<3%B0O9"%BQBT6AY<L4'F4:&?W(XAC1=+C>B '?K0 A
M;D?>*(;XXL!#>+R_/[0N_OC')[.;':"-VOG/N&PN%)%0RVK*.8%$1!$HI!&_
MD49&CO#,NX'/BR*V;LV -6/__VS/X@(?6I[/8L-$>^M:DFN0^^D2/!!)@%;&
MT3+8<%/"WA>"%_U.VAB19F,J8-B9BVH[-C)JVY6L0MSO0E]Q/H(L_R<U'TFS
MT'F /C*V-O*II*\QZZ2LL_+Y"8#*TB&$]P3E=??')\:-HF*&^U)@17),%CQG
M\ '%5[.WT>(DLK1Z(_I]*_<K)<VG*^O(- %"90GK*#C7FT0:&=6AKJX>WTT/
MQ=VDT9#6QFLH2IU=E*^@32Y^&#AZA=4F41^9M'H/_OC.5+.&1.13GFA+ 19I
M-U^3_+NY<NN/"LM3&%H*"TR^F&V.%4<:J#E@HS"]XKE9(Z1VZXUL30!AG@1F
MI)EMB#N-74<NH;I6V0=;$<BH(XR=&<8)U<6?Q68?.RM"M$"$L+#V/(\]= &O
M#)O'?6VZ!^#E3^<A,Z]Q59KFU.UEXKL1 )!&TYS=/(3;( &R9PG(:%C'YQER
MG9VG6@GC\S=R!*? E);G\Y@#_BD'%^@]6U*'4:?*\"P%N:1A(X7JH7;14-*R
MFX>:H==Q?V &>NTM8%$O*B@^N8,;A5EF'5[D?F)V43%XP^6+A0[F!!: \+T)
MZ_'$ '\.U-BPQ,H"'M3QV'"(*^OYH?,@I6P0.9-%2!76S7DBECL 9,PS@:*K
M"M,:O/':U\J3%O3!?V,L!3YT,VM1DGJ;AYBT0I/21F#_B?=6_&Y@ -=VIN43
MWDL   6R241!5(U)\J .SSJ]8%$/G0?^-F0.?)<UAA=2RI_NT61#9$(*W!9L
M1Y]OEH,F8&B-A'\.FXM7_[.8W:/X_OM/7 $+X<T^4&8@M@-D?)G1B>?QS@]K
M\"!1,]C[,Z\5P->=/])O.D_\\9UI^,QGJX5,S>?3E*,BD/$9A,:?@>YSLTKJ
MXH\G7_=G!D@"NO;>DE(R,,1] _?"N_NS/P]%_+Q1VJ@%-;>.!"Q)Q75(NE'=
M_+VX3N9Z=;:D%DE%M8(\:]BYM=E!BL<F?[[&KNU*VFY:RS*II!XSSI=BQ/$2
MC#AZ@U%)B$XRXG@Q/).+D'BC%A<$@12E>=BZIEAD2:E92$K-4-BS9)%0;>7%
M_T9+I%&>1&$@MR/I_I^ 0!87;.>1BVQ)."I;2K2EO-)RBA3JEL6\"?BRK!TI
M>H.\75FX:&=I- HY39%LOYH4W%CO2<%L:)24FFTS=AO5A<+C))W/8M%2*6CE
M5P&T-\K@/P%!\%X:RV)^):5FLO:75=R>O[)TK0.RE3_0G?Q<!79+)S<\T-W#
MZN(C4CE>RB@ 1<*EQ6M$LC"WA=XMR9>\0&YWLPEDE#G%+IJU,8'[0KI0O&T?
M&+Y8A)C$\[=;=K/2$V_'?<%VW$N>\]T#V)=O\(3U.'K.]M"E686IB50)W*$2
MH)#33/,3#@=U[FP-S!NEC2MV=13QV 4ROJ(T5AT],X*+3$  HO/ ,-,6G/E9
M'NJ%3]/2Q\5!!_'TFY,YH["S+_[WHUG8LD/LM]?29:KYJ1*X$R7PUMA5G,U,
M"&0&;[9P<4>4A\- QE>>//4'\KP99C\SL@!I!<6-G"G^V98Z$JGN50H41V-K
M%W\\WM\/<S<G*A+C6JI,-1]5 K\$"=0WW +Q]-9$)2ERTI3:N'#;0<ZV)9UL
M,'AC^MIXI23M?J_)0,;7F#2AOW\P@S.RN_CAO]^>RMP(&AILDRCY](X<R1;Q
MB7$39P=S"<#=>@]\/24$-'Y7-U4"J@3L2X!F@\G_E28\*,*(VX(8%IGB2M8-
MUH^(-$L+RZ1E%V''D8MX>_Q:KK\);6.DE3G1.IPF9.??WD2:_1HW[XEF QD5
M1RX-,]?OPV_Z^3%-B>QG%';$$6=96]4E'RV/A3%XZ%5. Z.IW#[?_,26[;*5
M3OU-E8 J ;$$: *$U@YEJRG1#"]146@-4+T;B^1**RW]>? 4W&<PSS+3S*I4
M$Z-K6CU*X#XD+J7]KVX+R/CJDX8T<E((-\-AMI_1=*H2 Y=/8^VX(OPHGGU[
MBMD.YH?_^7"6U84MK.6AWE<EH$J DT CD E9]T1,Y1<DID5TB0=(LY,*_#>Z
M[SP1;XY=B7H'%F)N+[FW")#QE:>@>KV_66ZQ93W2VQ?>2^.LNJ;PZ>A(B[QR
M=C ?IMV1F]3$Y3M!K&EU4R6@2J!Y$J"AY1_>I*$EQ7M3 "JA,5]X3@!&-FDG
M#Y"?)!%J._+6HD#&-W1MU''\Y=UIG%;EXH<_OSL=ZZ*5UQ&\G%F(S_T".=(A
MXX-YX,N (-4.Q@M3/:H2N T)U#<T8/Z6!+SRF=D_DY%RB51K=G7BR;X65RB.
M8?]@3Q/C:1(QMC-LK0)DU'!R$#8MB6.1+FFFD="]U\BEH$5+JVKJ0*O/3%Z]
MFXMIY4)\,!_T&KD$^T]RH9([@_#4.JH2Z"P2(!+[L90,S-ZP'Y_[!6&(VSIF
M.WNTMS>Z]#*"8L)15%GZC2*.7$P7KXC5T=O9:D#&-_QR9@&&3]S&C</)?M;-
ME;D^/-:'(@%,A-9E(O[RWG10_&]U4R6@2J#M)$#V,XIP2YX$2EX1;5>3VR^I
MU8&,K^+>XU?8S*/0]^KI-Z? M#0.)>6W[Z+ EZ,>50FH$KCS)-!F0,:+EER)
MR#GVR+E,7"]J/1(M7YYZ5"6@2N"7+X$V![)?ODC5%JH24"70UA)0@:RM):Z6
LITI E4"+2T %LA87J9JA*@%5 FTM@?\'B*F>=Z.@G?\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
